These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

509 related articles for article (PubMed ID: 27939146)

  • 1. Recombinant NDV expressing cytokines or fliC confers a quick immune response against NDV challenge and resistance to maternal antibody.
    Zhang T; Liu Y; Wang H; Zhang X; Zhu S; Xu P; Yin J; Ren G; Liu J; Li D
    Vet Microbiol; 2016 Nov; 196():107-117. PubMed ID: 27939146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Newcastle disease virus vectored infectious laryngotracheitis vaccines protect commercial broiler chickens in the presence of maternally derived antibodies.
    Yu Q; Spatz S; Li Y; Yang J; Zhao W; Zhang Z; Wen G; Garcia M; Zsak L
    Vaccine; 2017 Feb; 35(5):789-795. PubMed ID: 28052812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protection and antibody response caused by turkey herpesvirus vector Newcastle disease vaccine.
    Esaki M; Godoy A; Rosenberger JK; Rosenberger SC; Gardin Y; Yasuda A; Dorsey KM
    Avian Dis; 2013 Dec; 57(4):750-5. PubMed ID: 24597117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant Newcastle disease virus (NDV) La Sota expressing the haemagglutinin-neuraminidase protein of genotype VII NDV shows improved protection efficacy against NDV challenge.
    Bu YW; Yang HM; Jin JH; Zhao J; Xue J; Zhang GZ
    Avian Pathol; 2019 Apr; 48(2):91-97. PubMed ID: 30465608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A recombinant Newcastle disease virus (NDV) expressing infectious laryngotracheitis virus (ILTV) surface glycoprotein D protects against highly virulent ILTV and NDV challenges in chickens.
    Kanabagatte Basavarajappa M; Kumar S; Khattar SK; Gebreluul GT; Paldurai A; Samal SK
    Vaccine; 2014 Jun; 32(28):3555-63. PubMed ID: 24793943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant paramyxovirus type 1-avian influenza-H7 virus as a vaccine for protection of chickens against influenza and Newcastle disease.
    Swayne DE; Suarez DL; Schultz-Cherry S; Tumpey TM; King DJ; Nakaya T; Palese P; Garcia-Sastre A
    Avian Dis; 2003; 47(3 Suppl):1047-50. PubMed ID: 14575108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of phylogenetic diversity of velogenic Newcastle disease virus challenge on virus shedding post homologous and heterologous DNA vaccination in chickens.
    Mohamed MH; Abdelaziz AM; Kumar S; Al-Habib MA; Megahed MM
    Avian Pathol; 2016; 45(2):228-34. PubMed ID: 26813237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Re-evaluation the immune efficacy of Newcastle disease virus vaccine in commercial laying chickens.
    Han Q; Gao X; Wu P; Xiao S; Wang X; Liu P; Tong L; Hao H; Zhang S; Dang R; Yang Z
    Res Vet Sci; 2017 Apr; 111():63-66. PubMed ID: 28043009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the Impact of Different Administration Routes on the Efficacy of a Thermoresistant Newcastle Disease Vaccine in Chickens.
    Hassanzadeh M; Abdoshah M; Yousefi AR; Masoudi S
    Viral Immunol; 2020 Jun; 33(5):361-366. PubMed ID: 31976824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stronger Interference of Avian Influenza Virus-Specific Than Newcastle Disease Virus-Specific Maternally Derived Antibodies with a Recombinant NDV-H5 Vaccine.
    Lardinois A; Vandersleyen O; Steensels M; Desloges N; Mast J; van den Berg T; Lambrecht B
    Avian Dis; 2016 May; 60(1 Suppl):191-201. PubMed ID: 27309055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advancement in vaccination against Newcastle disease: recombinant HVT NDV provides high clinical protection and reduces challenge virus shedding with the absence of vaccine reactions.
    Palya V; Kiss I; Tatár-Kis T; Mató T; Felföldi B; Gardin Y
    Avian Dis; 2012 Jun; 56(2):282-7. PubMed ID: 22856183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant infectious bronchitis virus (IBV) H120 vaccine strain expressing the hemagglutinin-neuraminidase (HN) protein of Newcastle disease virus (NDV) protects chickens against IBV and NDV challenge.
    Yang X; Zhou Y; Li J; Fu L; Ji G; Zeng F; Zhou L; Gao W; Wang H
    Arch Virol; 2016 May; 161(5):1209-16. PubMed ID: 26873815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the immune responses of biological adjuvant bivalent vaccine with three different insertion modes for ND and IBD.
    Sun W; Li S; Niu D; Qin R; Li H; Xue Z; Guo Y; Liu J; Liu Y; Jiang X; Yin J; Guo X; Ren G
    Virulence; 2024 Dec; 15(1):2387181. PubMed ID: 39101682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced serologic response to Newcastle disease virus in broiler chickens exposed to a Chinese field strain of subgroup J avian leukosis virus.
    Cui Z; Sun S; Wang J
    Avian Dis; 2006 Jun; 50(2):191-5. PubMed ID: 16863066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Newcastle disease virus (NDV) recombinants expressing infectious laryngotracheitis virus (ILTV) glycoproteins gB and gD protect chickens against ILTV and NDV challenges.
    Zhao W; Spatz S; Zhang Z; Wen G; Garcia M; Zsak L; Yu Q
    J Virol; 2014 Aug; 88(15):8397-406. PubMed ID: 24829337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant-attenuated
    Ding K; Shang K; Yu ZH; Yu C; Jia YY; He L; Liao CS; Li J; Zhang CJ; Li YJ; Wu TC; Cheng XC
    J Vet Sci; 2018 Mar; 19(2):232-241. PubMed ID: 29032660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathogenicity and immunogenicity of different recombinant Newcastle disease virus clone 30 variants after in ovo vaccination.
    Ramp K; Topfstedt E; Wäckerlin R; Höper D; Ziller M; Mettenleiter TC; Grund C; Römer-Oberdörfer A
    Avian Dis; 2012 Mar; 56(1):208-17. PubMed ID: 22545548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of live LaSota vaccine strain-induced protection in chickens upon early challenge with a virulent Newcastle disease virus of heterologous genotype.
    Cornax I; Miller PJ; Afonso CL
    Avian Dis; 2012 Sep; 56(3):464-70. PubMed ID: 23050461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can genotype mismatch really affect the level of protection conferred by Newcastle disease vaccines against heterologous virulent strains?
    Liu H; de Almeida RS; Gil P; Majó N; Nofrarías M; Briand FX; Jestin V; Albina E
    Vaccine; 2018 Jun; 36(27):3917-3925. PubMed ID: 29843999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simultaneous Expression of Chicken Granulocyte Monocyte Colony-Stimulating Factor and the Hemagglutinin-Neuraminidase Epitope of the Virulent Newcastle Disease Virus Genotype VII C22 Strain in a Functional Synthetic Recombinant Adenovirus as a Genotype-Matched Vaccine with Potential Antiviral Activity.
    Adam FEA; Zhao X; Guan Z; Chang Z; Thrusfield M; Lu K; El Tigani-Asil ETA; Terab AMA; Ismael M; Tong L; Prince-Theodore DW; Luo C; Xiao S; Wang X; Liu H; Yang Z
    Microbiol Spectr; 2023 Jun; 11(3):e0402422. PubMed ID: 37036344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.